In the latest session, Pulse Biosciences Inc (NASDAQ: PLSE) closed at $8.71 up 3.69% from its previous closing price of $8.40. In other words, the price has increased by $+0.31 from its previous closing price. On the day, 280498 shares were traded.
Ratios:
For a deeper understanding of Pulse Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.50 and its Current Ratio is at 9.50. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on July 27, 2021, initiated with a Overweight rating and assigned the stock a target price of $28.
On March 11, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $40.
H.C. Wainwright reiterated its Buy rating for the stock on January 26, 2021, while the target price for the stock was revised from $16 to $40.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 12 ’23 when DUGGAN ROBERT W bought 17,999 shares for $9.15 per share. The transaction valued at 164,691 led to the insider holds 36,984,179 shares of the business.
DUGGAN ROBERT W bought 90,118 shares of PLSE for $843,504 on Dec 11 ’23. The Director now owns 36,966,180 shares after completing the transaction at $9.36 per share. On Dec 08 ’23, another insider, DUGGAN ROBERT W, who serves as the Director of the company, bought 116,656 shares for $9.54 each. As a result, the insider paid 1,112,898 and bolstered with 36,876,062 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PLSE now has a Market Capitalization of 479.75M and an Enterprise Value of 438.75M. Its current Enterprise Value per Revenue stands at -48.75k whereas that against EBITDA is -11.38.
Stock Price History:
The Beta on a monthly basis for PLSE is 1.67, which has changed by 159.23% over the last 52 weeks, in comparison to a change of 27.86% over the same period for the S&P500. Over the past 52 weeks, PLSE has reached a high of $13.62, while it has fallen to a 52-week low of $2.36. The 50-Day Moving Average of the stock is 9.25, while the 200-Day Moving Average is calculated to be 7.36.
Shares Statistics:
For the past three months, PLSE has traded an average of 182.46K shares per day and 151.6k over the past ten days. A total of 37.23M shares are outstanding, with a floating share count of 16.17M. Insiders hold about 70.61% of the company’s shares, while institutions hold 8.12% stake in the company. Shares short for PLSE as of Mar 15, 2024 were 2.5M with a Short Ratio of 13.68, compared to 2.6M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.53% and a Short% of Float of 14.42%.
Earnings Estimates
There are 0 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.49. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
